ERIS price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- ERIS
- MB Code
- MBEQU2612
- ISIN
- INE406M01024
- BSE code
- 540596
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 756.56 Cr
- Net profit
- 279.1 Cr
- EPS
- 20.57
- YoY revenue
- +7.27%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for ERIS
Dividend of ₹7.21 per share
Ex-date corporate action
EPS 20.57 vs est. 10.20
Beat estimates by 101.67%
Eris Lifesciences Q4FY26 net profit nearly tripled to ₹281.6 crore on a ₹132.2 crore deferred tax gain; revenue rose 7.3% and the board d…
Eris Lifesciences rose 8.57% after reporting Q4 FY26 consolidated PAT jumped 200.09% YoY to Rs 281.61 crore from Rs 93.84 crore in Q4 FY25.
EPS 8.60 vs est. 10.61
Missed estimates by 18.93%
Prabhudas Lilladher recommends a buy on Eris Lifesciences with a target price of Rs 1975.
EPS 8.64 vs est. 8.36
Beat estimates by 3.30%
Eris Lifesciences' share price is currently ₹1624.1 on the BSE. The stock has seen fluctuations today, indicating market volatility.
Price returns
Historical performance
Technicals
Indicator consensus